beamtherapeutics

Senior Medical Science Liaison/Medical Science Liaison – Southwest Region

Apply Now

At a Glance

Location
LA/Phoenix
Work Regime
remote
Experience
10+ years
Posted
2026-03-24T12:05:20-04:00

Key Requirements

Domain Knowledge

  • Biotech
  • Clinical
  • Education
  • Medical
  • Regulatory

Requirements

~10+ years industry experience in Medical Affairs with significant Field Medical tenure.

Rare disease expertise required; hematology strongly preferred with emphasis on SCD.

Small biotech experience preferred; demonstrated impact in resource‑constrained settings.

Launch experience (pre‑approval to post‑launch), ideally in CGT or complex specialty (buy‑and‑bill) environments.

Proven territory management and account planning capability across complex ecosystems (academic centers, community networks, payers, advocacy).

Cross‑functional collaboration with Clinical, Regulatory, Commercial, Medical Operations, and Publications while maintaining medical/scientific integrity.

Responsibilities

We are building a best‑in‑class Field Medical organization as a natural next step in the growth of our Medical Affairs organization at Beam therapeutics!

This Director (or Associate Director) level MSL will own a defined US territory with primary responsibility in sickle cell disease (SCD) and shared accountability across the Beam pipeline, including Alpha‑1 antitrypsin deficiency (Alpha‑1) and glycogen storage disease 1a (GSD).

You will architect territory strategy, onboard priority treatment centers, engage KOLs and HCPs, generate actionable insights, and drive pre‑commercial launch readiness in close collaboration with cross‑functional partners.

Develop and execute territory strategy: map treatment centers, referral networks, transplant/infusion sites, cell-collection capabilities, payers, and advocacy groups; prioritize accounts and set measurable objectives.

Support treatment center onboarding: coordinate scientific and operational readiness aligned with SOPs, compliance, and patient journey requirements; partner with internal teams for qualification and activation.

Build trusted relationships with KOLs and HCPs: deliver fair-balanced, evidence-based education on rare diseases, cell and gene therapy science, and Beam’s platform; foster advocacy and awareness.